title: Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women.
abstract: OBJECTIVE
  To report on the issues encountered in the recruitment of healthy naturally menopausal women in the community to a randomized placebo-controlled trial of dehydroepiandrosterone (DHEA) therapy for treatment of loss of sexual desire.
  
  
  METHODS
  Recruitment of women was achieved by advertising and media publicity. We have reported on the method by which women initially contacted us and the reasons for nonparticipation.
  
  
  RESULTS
  Nine hundred and eighteen women contacted us about participating in the study; 706 of these were telephoned screened, and 93 of these (10%) women were randomized to therapy. The main determinants for nonparticipation included ineligibility on phone screening (58%), withdrawal of interest either before or after screening (55%), and preexisting pathology after attending for screening (8%).
  
  
  CONCLUSIONS
  Despite ongoing interest by women to participate in research for therapies to treat low libido, concerns about the use of any hormonal treatment and the time poverty experienced by many women at midlife present new barriers to recruitment and need to be considered in assessing the feasibility of studies in this field.
authors.affiliation: NH&MRC Centre of Clinical Research Excellence in the Women's Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia.
authors.forename: Mary
authors.initials: M
authors.lastname: Panjari
authors.forename: Robin
authors.initials: R
authors.lastname: Bell
authors.forename: Jenny
authors.initials: J
authors.lastname: Adams
authors.forename: Corallee
authors.initials: C
authors.lastname: Morrow
authors.forename: Mary-Anne
authors.initials: MA
authors.lastname: Papalia
authors.forename: Jill
authors.initials: J
authors.lastname: Astbury
authors.forename: Susan R
authors.initials: SR
authors.lastname: Davis
mesh_terms: D000368:Aged; D001315:Australia; D003687:Dehydroepiandrosterone / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007989:Libido; D008875:Middle Aged; D018579:Patient Selection; D010919:Placebos; D017698:Postmenopause; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy; D012959:Socioeconomic Factors; D016387:Women's Health
chemical_list: D010919:Placebos; D003687:Dehydroepiandrosterone